Department of Internal Medicine, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou 215003, China.
2 Department of Internal Medicine, The Affiliated Suzhou Science and Technology Town Hospital of Nanjing Medical University, Suzhou 215153, China.
J Tradit Chin Med. 2024 Oct;44(5):885-895. doi: 10.19852/j.cnki.jtcm.20240806.006.
To investigate the mechanism of the protective effect of modified Pulsatilla decoction (, MPD) on the mechanical barrier of the ulcerative colitis (UC) intestinal epithelium and .
We established an intestinal epithelial crypt cell line-6 cell barrier injury model by using lipopolysaccharide (LPS). The model was then treated with p38 mitogen-activated protein kinase-myosin light chain kinase (p38MAPK-MLCK) pathway inhibitors, p38MAPK-MLCK pathway silencing genes (si-p38MAPK, si-NF-κB, and si-MLCK), and MPD respectively. Transepithelial electronic resistance (TEER) measurements and permeability assays were performed to assess barrier function. Immunofluorescence staining of tight junctions (TJ) was performed. In experiment, dextran sodium sulfate-induced colitis rat model was conducted to evaluate the effect of MPD and mesalazine on UC. The rats were scored using the disease activity index based on their clinical symptoms. Transmission electron microscopy and hematoxylin-eosin staining were used to examine morphological changes in UC rats. Western blotting and real-time quantitative polymerase chain reaction were performed to examine the gene and protein expression of significant differential molecules.
In study, LPS-induced intestinal barrier dysfunction was inhibited by p38MAPK-MLCK pathway inhibitors and p38MAPK-MLCK pathway gene silencing. Silencing of p38MAPK-MLCK pathway genes decreased TJ expression. MPD treatment partly restored the LPS-induced decreased in TEER and increase in permeability. MPD increased the gene and protein expression of TJ, while down-regulated the LPS-induced high expression of p-p38MAPK and p-MLC. In UC model rats, MPD could ameliorate body weight loss and disease activity index, relieve colonic pathology, up-regulate TJ expression as well as decrease the expression of p-p38MAPK and p-MLC in UC rat colonic mucosal tissue.
The p38MAPK-MLCK signaling pathway can affect mechanical barrier function and TJ expression in the intestinal epithelium. MPD restores TJ expression and attenuates intestinal epithelial barrier damage by suppressing the p38MAPK-MLCK pathway.
研究加味白头翁汤(MPD)对溃疡性结肠炎(UC)肠上皮机械屏障的保护作用机制。
采用脂多糖(LPS)建立肠上皮隐窝细胞系-6 细胞屏障损伤模型。然后用 p38 丝裂原活化蛋白激酶-肌球蛋白轻链激酶(p38MAPK-MLCK)通路抑制剂、p38MAPK-MLCK 通路沉默基因(si-p38MAPK、si-NF-κB 和 si-MLCK)和 MPD 分别处理模型。通过跨上皮电阻(TEER)测量和通透性测定评估屏障功能。进行紧密连接(TJ)免疫荧光染色。在实验中,采用葡聚糖硫酸钠诱导的结肠炎大鼠模型评价 MPD 和美沙拉嗪对 UC 的作用。根据临床症状对大鼠进行疾病活动指数评分。采用透射电子显微镜和苏木精-伊红染色观察 UC 大鼠的形态学变化。采用 Western blot 和实时定量聚合酶链反应检测差异表达分子的基因和蛋白表达。
在研究中,LPS 诱导的肠屏障功能障碍被 p38MAPK-MLCK 通路抑制剂和 p38MAPK-MLCK 通路基因沉默所抑制。沉默 p38MAPK-MLCK 通路基因降低了 TJ 的表达。MPD 治疗部分恢复了 LPS 诱导的 TEER 降低和通透性增加。MPD 增加了 TJ 的基因和蛋白表达,同时下调了 LPS 诱导的 p-p38MAPK 和 p-MLC 的高表达。在 UC 模型大鼠中,MPD 可改善体重减轻和疾病活动指数,缓解结肠病理,上调 TJ 表达,并降低 UC 大鼠结肠黏膜组织中 p-p38MAPK 和 p-MLC 的表达。
p38MAPK-MLCK 信号通路可影响肠上皮的机械屏障功能和 TJ 表达。MPD 通过抑制 p38MAPK-MLCK 通路恢复 TJ 表达并减轻肠上皮屏障损伤。